At the start of the meeting, Abdel Ghaffar welcomed the
participants and thanked ACDIMA’s representatives for their efforts in
supporting the healthcare sector, particularly in advancing the pharmaceutical
industry. He stressed the importance of continuing this strategic partnership
to strengthen Egypt’s capabilities in this vital field.
Dr. Hossam Abdel Ghaffar, official spokesperson for the
Ministry of Health, said the Minister reaffirmed the state’s commitment to
expanding investment in pharmaceutical manufacturing to meet local demand for
medicines and medical supplies, ensure citizens have access to safe and
reliable drugs, achieve self-sufficiency, and open new markets for exports.
The meeting also discussed investment opportunities in new
pharmaceutical markets, Egypt’s competitiveness in regional and international
exports, and expansion plans for biopharmaceutical production, with ACDIMA
playing a key national role in meeting Egypt’s pharmaceutical needs.
The Minister reviewed the company’s financial statements and
discussed achievements in pharmaceutical investment and localization, including
partnerships with leading global firms to manufacture medicines in Egypt. This
aligns with the state’s vision to strengthen domestic pharmaceutical industries
and consolidate Egypt’s position as a leading regional hub for pharmaceuticals
in the Middle East and Africa.
The meeting was also attended by Dr. Mohamed El-Tayeb,
Deputy Minister of Health; Dr. Olfat Ghorab, Chairwoman of ACDIMA; Fetouh
Salama, Financial Advisor to ACDIMA Holding; and Counselor Ahmed Weshahi, Legal
Advisor to ACDIMA Holding. Joining via video conference were Counselor Mohamed
El-Menshawy, Legal Advisor to the Deputy Prime Minister and Minister of Health;
Counselor Moustafa El-Bahetymi, Advisor to the Minister of Justice for
International Arbitration; Abdel Halim Omar, Advisor to the Minister of
Finance; and Dr. Sener El-Ahdal, Supervisor of the European Cooperation Sector
at the Ministry of Planning.